National Vaccine
Information Center

Your Health. Your Family. Your Choice.

MedAlerts.org
Search Results

This is VAERS ID 370667

Government Disclaimer on use of this data

History of Changes from the VAERS Wayback Machine

First Appeared on 12/8/2009

VAERS ID: 370667
VAERS Form:
Age:14.0
Sex:Female
Location:Foreign
Vaccinated:2009-11-05
Onset:2009-11-07
Submitted:2009-11-30
Entered:2009-11-30
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
HPV2: HPV (CERVARIX) / GLAXOSMITHKLINE BIOLOGICALS AHPVA057CA / 1 UN / IM

Administered by: Other      Purchased by: Other
Symptoms: Epilepsy

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? Yes
Office Visit (V2.0)? No
ER or Office Visit (V1.0)? No
ER or ED Visit (V2.0)? No
Hospitalized? Yes, days: 1     Extended hospital stay? No
Previous Vaccinations:
Other Medications:
Current Illness: Unknown
Preexisting Conditions:
Allergies:
Diagnostic Lab Data: UNK
CDC 'Split Type': B0607037A

Write-up: This case was reported by a foreign regulatory authority (Agency # GB-MHRA-ADR 20528079) and described the occurrence of epileptic fit in a 14-year-old female subject who was vaccinated with CERVARIX (GlaxoSmithKline). On 5 November 2009 the subject received an unspecified dose of CERVARIX (intramuscular, batch: AHPVA057CA). On 7 November 2009, 2 days after vaccination with the 2nd dose of CERVARIX, the subject experienced the first epileptic fit. The subject was hospitalised over night for observation. The subject had 2nd fits the next night and was due to be seen by consultant paediatrician in four months or sooner should a further fit occur. At the time of reporting the event was resolved. Agency Verbatim Text: Had 1st epileptic fit 2 days after receiving the 2nd dose of CERVARIX. Was admitted overnight for observation. Had 2nd fit the next night. Due to be seen by consultant paediatrician in four months or sooner should a further fit occur.


Changed on 9/14/2017

VAERS ID: 370667 Before After
VAERS Form:(blank) 1
Age:14.0
Sex:Female
Location:Foreign
Vaccinated:2009-11-05
Onset:2009-11-07
Submitted:2009-11-30
Entered:2009-11-30
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
HPV2: HPV (CERVARIX) / GLAXOSMITHKLINE BIOLOGICALS AHPVA057CA / 1 2 UN / IM

Administered by: Other      Purchased by: Other
Symptoms: Epilepsy

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? Yes
Office Visit (V2.0)? No
ER or Office Visit (V1.0)? No
ER or ED Visit (V2.0)? No
Hospitalized? Yes, days: 1     Extended hospital stay? No
Previous Vaccinations:
Other Medications:
Current Illness: Unknown
Preexisting Conditions:
Allergies:
Diagnostic Lab Data: UNK
CDC 'Split Type': B0607037A

Write-up: This case was reported by a foreign regulatory authority (Agency # GB-MHRA-ADR 20528079) and described the occurrence of epileptic fit in a 14-year-old female subject who was vaccinated with CERVARIX (GlaxoSmithKline). On 5 November 2009 the subject received an unspecified dose of CERVARIX (intramuscular, batch: AHPVA057CA). On 7 November 2009, 2 days after vaccination with the 2nd dose of CERVARIX, the subject experienced the first epileptic fit. The subject was hospitalised over night for observation. The subject had 2nd fits the next night and was due to be seen by consultant paediatrician in four months or sooner should a further fit occur. At the time of reporting the event was resolved. Agency Verbatim Text: Had 1st epileptic fit 2 days after receiving the 2nd dose of CERVARIX. Was admitted overnight for observation. Had 2nd fit the next night. Due to be seen by consultant paediatrician in four months or sooner should a further fit occur.


Changed on 2/14/2018

VAERS ID: 370667 Before After
VAERS Form:1
Age:14.0
Sex:Female
Location:Foreign
Vaccinated:2009-11-05
Onset:2009-11-07
Submitted:2009-11-30
Entered:2009-11-30
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
HPV2: HPV (CERVARIX) / GLAXOSMITHKLINE BIOLOGICALS AHPVA057CA / 2 UN / IM

Administered by: Other      Purchased by: Other
Symptoms: Epilepsy

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? Yes
Office Visit (V2.0)? No
ER or Office Visit (V1.0)? No
ER or ED Visit (V2.0)? No
Hospitalized? Yes, days: 1     Extended hospital stay? No
Previous Vaccinations:
Other Medications:
Current Illness: Unknown
Preexisting Conditions:
Allergies:
Diagnostic Lab Data: UNK
CDC 'Split Type': B0607037A

Write-up: This case was reported by a foreign regulatory authority (Agency # GB-MHRA-ADR 20528079) and described the occurrence of epileptic fit in a 14-year-old female subject who was vaccinated with CERVARIX (GlaxoSmithKline). On 5 November 2009 the subject received an unspecified dose of CERVARIX (intramuscular, batch: AHPVA057CA). On 7 November 2009, 2 days after vaccination with the 2nd dose of CERVARIX, the subject experienced the first epileptic fit. The subject was hospitalised over night for observation. The subject had 2nd fits the next night and was due to be seen by consultant paediatrician in four months or sooner should a further fit occur. At the time of reporting the event was resolved. Agency Verbatim Text: Had 1st epileptic fit 2 days after receiving the 2nd dose of CERVARIX. Was admitted overnight for observation. Had 2nd fit the next night. Due to be seen by consultant paediatrician in four months or sooner should a further fit occur.


Changed on 6/14/2018

VAERS ID: 370667 Before After
VAERS Form:1
Age:14.0
Sex:Female
Location:Foreign
Vaccinated:2009-11-05
Onset:2009-11-07
Submitted:2009-11-30
Entered:2009-11-30
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
HPV2: HPV (CERVARIX) / GLAXOSMITHKLINE BIOLOGICALS AHPVA057CA / 2 UN / IM

Administered by: Other      Purchased by: Other
Symptoms: Epilepsy

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? Yes
Office Visit (V2.0)? No
ER or Office Visit (V1.0)? No
ER or ED Visit (V2.0)? No
Hospitalized? Yes, days: 1     Extended hospital stay? No
Previous Vaccinations:
Other Medications:
Current Illness: Unknown
Preexisting Conditions:
Allergies:
Diagnostic Lab Data: UNK
CDC 'Split Type': B0607037A

Write-up: This case was reported by a foreign regulatory authority (Agency # GB-MHRA-ADR 20528079) and described the occurrence of epileptic fit in a 14-year-old female subject who was vaccinated with CERVARIX (GlaxoSmithKline). On 5 November 2009 the subject received an unspecified dose of CERVARIX (intramuscular, batch: AHPVA057CA). On 7 November 2009, 2 days after vaccination with the 2nd dose of CERVARIX, the subject experienced the first epileptic fit. The subject was hospitalised over night for observation. The subject had 2nd fits the next night and was due to be seen by consultant paediatrician in four months or sooner should a further fit occur. At the time of reporting the event was resolved. Agency Verbatim Text: Had 1st epileptic fit 2 days after receiving the 2nd dose of CERVARIX. Was admitted overnight for observation. Had 2nd fit the next night. Due to be seen by consultant paediatrician in four months or sooner should a further fit occur.


Changed on 8/14/2018

VAERS ID: 370667 Before After
VAERS Form:1
Age:14.0
Sex:Female
Location:Foreign
Vaccinated:2009-11-05
Onset:2009-11-07
Submitted:2009-11-30
Entered:2009-11-30
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
HPV2: HPV (CERVARIX) / GLAXOSMITHKLINE BIOLOGICALS AHPVA057CA / 2 UN / IM

Administered by: Other      Purchased by: Other
Symptoms: Epilepsy

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? Yes
Office Visit (V2.0)? No
ER or Office Visit (V1.0)? No
ER or ED Visit (V2.0)? No
Hospitalized? Yes, days: 1     Extended hospital stay? No
Previous Vaccinations:
Other Medications:
Current Illness: Unknown
Preexisting Conditions:
Allergies:
Diagnostic Lab Data: UNK
CDC 'Split Type': B0607037A

Write-up: This case was reported by a foreign regulatory authority (Agency # GB-MHRA-ADR 20528079) and described the occurrence of epileptic fit in a 14-year-old female subject who was vaccinated with CERVARIX (GlaxoSmithKline). On 5 November 2009 the subject received an unspecified dose of CERVARIX (intramuscular, batch: AHPVA057CA). On 7 November 2009, 2 days after vaccination with the 2nd dose of CERVARIX, the subject experienced the first epileptic fit. The subject was hospitalised over night for observation. The subject had 2nd fits the next night and was due to be seen by consultant paediatrician in four months or sooner should a further fit occur. At the time of reporting the event was resolved. Agency Verbatim Text: Had 1st epileptic fit 2 days after receiving the 2nd dose of CERVARIX. Was admitted overnight for observation. Had 2nd fit the next night. Due to be seen by consultant paediatrician in four months or sooner should a further fit occur.


Changed on 9/14/2018

VAERS ID: 370667 Before After
VAERS Form:1
Age:14.0
Sex:Female
Location:Foreign
Vaccinated:2009-11-05
Onset:2009-11-07
Submitted:2009-11-30
Entered:2009-11-30
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
HPV2: HPV (CERVARIX) / GLAXOSMITHKLINE BIOLOGICALS AHPVA057CA / 2 UN / IM

Administered by: Other      Purchased by: Other
Symptoms: Epilepsy

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? Yes
Office Visit (V2.0)? No
ER or Office Visit (V1.0)? No
ER or ED Visit (V2.0)? No
Hospitalized? Yes, days: 1     Extended hospital stay? No
Previous Vaccinations:
Other Medications:
Current Illness: Unknown
Preexisting Conditions:
Allergies:
Diagnostic Lab Data: UNK
CDC 'Split Type': B0607037A

Write-up: This case was reported by a foreign regulatory authority (Agency # GB-MHRA-ADR 20528079) and described the occurrence of epileptic fit in a 14-year-old female subject who was vaccinated with CERVARIX (GlaxoSmithKline). On 5 November 2009 the subject received an unspecified dose of CERVARIX (intramuscular, batch: AHPVA057CA). On 7 November 2009, 2 days after vaccination with the 2nd dose of CERVARIX, the subject experienced the first epileptic fit. The subject was hospitalised over night for observation. The subject had 2nd fits the next night and was due to be seen by consultant paediatrician in four months or sooner should a further fit occur. At the time of reporting the event was resolved. Agency Verbatim Text: Had 1st epileptic fit 2 days after receiving the 2nd dose of CERVARIX. Was admitted overnight for observation. Had 2nd fit the next night. Due to be seen by consultant paediatrician in four months or sooner should a further fit occur.


Changed on 10/14/2018

VAERS ID: 370667 Before After
VAERS Form:1
Age:14.0
Sex:Female
Location:Foreign
Vaccinated:2009-11-05
Onset:2009-11-07
Submitted:2009-11-30
Entered:2009-11-30
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
HPV2: HPV (CERVARIX) / GLAXOSMITHKLINE BIOLOGICALS AHPVA057CA / 2 UN / IM

Administered by: Other      Purchased by: Other
Symptoms: Epilepsy

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? Yes
Office Visit (V2.0)? No
ER or Office Visit (V1.0)? No
ER or ED Visit (V2.0)? No
Hospitalized? Yes, days: 1     Extended hospital stay? No
Previous Vaccinations:
Other Medications:
Current Illness: Unknown
Preexisting Conditions:
Allergies:
Diagnostic Lab Data: UNK
CDC 'Split Type': B0607037A

Write-up: This case was reported by a foreign regulatory authority (Agency # GB-MHRA-ADR 20528079) and described the occurrence of epileptic fit in a 14-year-old female subject who was vaccinated with CERVARIX (GlaxoSmithKline). On 5 November 2009 the subject received an unspecified dose of CERVARIX (intramuscular, batch: AHPVA057CA). On 7 November 2009, 2 days after vaccination with the 2nd dose of CERVARIX, the subject experienced the first epileptic fit. The subject was hospitalised over night for observation. The subject had 2nd fits the next night and was due to be seen by consultant paediatrician in four months or sooner should a further fit occur. At the time of reporting the event was resolved. Agency Verbatim Text: Had 1st epileptic fit 2 days after receiving the 2nd dose of CERVARIX. Was admitted overnight for observation. Had 2nd fit the next night. Due to be seen by consultant paediatrician in four months or sooner should a further fit occur.


Changed on 12/24/2020

VAERS ID: 370667 Before After
VAERS Form:1
Age:14.0
Sex:Female
Location:Foreign
Vaccinated:2009-11-05
Onset:2009-11-07
Submitted:2009-11-30
Entered:2009-11-30
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
HPV2: HPV (CERVARIX) / GLAXOSMITHKLINE BIOLOGICALS AHPVA057CA / 2 UN / IM

Administered by: Other      Purchased by: Other
Symptoms: Epilepsy

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? Yes
Office Visit (V2.0)? No
ER or Office Visit (V1.0)? No
ER or ED Visit (V2.0)? No
Hospitalized? Yes, days: 1     Extended hospital stay? No
Previous Vaccinations:
Other Medications:
Current Illness: Unknown
Preexisting Conditions:
Allergies:
Diagnostic Lab Data: UNK
CDC 'Split Type': B0607037A

Write-up: This case was reported by a foreign regulatory authority (Agency # GB-MHRA-ADR 20528079) and described the occurrence of epileptic fit in a 14-year-old female subject who was vaccinated with CERVARIX (GlaxoSmithKline). On 5 November 2009 the subject received an unspecified dose of CERVARIX (intramuscular, batch: AHPVA057CA). On 7 November 2009, 2 days after vaccination with the 2nd dose of CERVARIX, the subject experienced the first epileptic fit. The subject was hospitalised over night for observation. The subject had 2nd fits the next night and was due to be seen by consultant paediatrician in four months or sooner should a further fit occur. At the time of reporting the event was resolved. Agency Verbatim Text: Had 1st epileptic fit 2 days after receiving the 2nd dose of CERVARIX. Was admitted overnight for observation. Had 2nd fit the next night. Due to be seen by consultant paediatrician in four months or sooner should a further fit occur.


Changed on 12/30/2020

VAERS ID: 370667 Before After
VAERS Form:1
Age:14.0
Sex:Female
Location:Foreign
Vaccinated:2009-11-05
Onset:2009-11-07
Submitted:2009-11-30
Entered:2009-11-30
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
HPV2: HPV (CERVARIX) / GLAXOSMITHKLINE BIOLOGICALS AHPVA057CA / 2 UN / IM

Administered by: Other      Purchased by: Other
Symptoms: Epilepsy

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? Yes
Office Visit (V2.0)? No
ER or Office Visit (V1.0)? No
ER or ED Visit (V2.0)? No
Hospitalized? Yes, days: 1     Extended hospital stay? No
Previous Vaccinations:
Other Medications:
Current Illness: Unknown
Preexisting Conditions:
Allergies:
Diagnostic Lab Data: UNK
CDC 'Split Type': B0607037A

Write-up: This case was reported by a foreign regulatory authority (Agency # GB-MHRA-ADR 20528079) and described the occurrence of epileptic fit in a 14-year-old female subject who was vaccinated with CERVARIX (GlaxoSmithKline). On 5 November 2009 the subject received an unspecified dose of CERVARIX (intramuscular, batch: AHPVA057CA). On 7 November 2009, 2 days after vaccination with the 2nd dose of CERVARIX, the subject experienced the first epileptic fit. The subject was hospitalised over night for observation. The subject had 2nd fits the next night and was due to be seen by consultant paediatrician in four months or sooner should a further fit occur. At the time of reporting the event was resolved. Agency Verbatim Text: Had 1st epileptic fit 2 days after receiving the 2nd dose of CERVARIX. Was admitted overnight for observation. Had 2nd fit the next night. Due to be seen by consultant paediatrician in four months or sooner should a further fit occur.


Changed on 5/7/2021

VAERS ID: 370667 Before After
VAERS Form:1
Age:14.0
Sex:Female
Location:Foreign
Vaccinated:2009-11-05
Onset:2009-11-07
Submitted:2009-11-30
Entered:2009-11-30
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
HPV2: HPV (CERVARIX) / GLAXOSMITHKLINE BIOLOGICALS AHPVA057CA / 2 UN / IM

Administered by: Other      Purchased by: Other
Symptoms: Epilepsy

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? Yes
Office Visit (V2.0)? No
ER or Office Visit (V1.0)? No
ER or ED Visit (V2.0)? No
Hospitalized? Yes, days: 1     Extended hospital stay? No
Previous Vaccinations:
Other Medications:
Current Illness: Unknown
Preexisting Conditions:
Allergies:
Diagnostic Lab Data: UNK
CDC 'Split Type': B0607037A

Write-up: This case was reported by a foreign regulatory authority (Agency # GB-MHRA-ADR 20528079) and described the occurrence of epileptic fit in a 14-year-old female subject who was vaccinated with CERVARIX (GlaxoSmithKline). On 5 November 2009 the subject received an unspecified dose of CERVARIX (intramuscular, batch: AHPVA057CA). On 7 November 2009, 2 days after vaccination with the 2nd dose of CERVARIX, the subject experienced the first epileptic fit. The subject was hospitalised over night for observation. The subject had 2nd fits the next night and was due to be seen by consultant paediatrician in four months or sooner should a further fit occur. At the time of reporting the event was resolved. Agency Verbatim Text: Had 1st epileptic fit 2 days after receiving the 2nd dose of CERVARIX. Was admitted overnight for observation. Had 2nd fit the next night. Due to be seen by consultant paediatrician in four months or sooner should a further fit occur.


Changed on 5/21/2021

VAERS ID: 370667 Before After
VAERS Form:1
Age:14.0
Sex:Female
Location:Foreign
Vaccinated:2009-11-05
Onset:2009-11-07
Submitted:2009-11-30
Entered:2009-11-30
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
HPV2: HPV (CERVARIX) / GLAXOSMITHKLINE BIOLOGICALS AHPVA057CA / 2 UN / IM

Administered by: Other      Purchased by: Other
Symptoms: Epilepsy

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? Yes
Office Visit (V2.0)? No
ER or Office Visit (V1.0)? No
ER or ED Visit (V2.0)? No
Hospitalized? Yes, days: 1     Extended hospital stay? No
Previous Vaccinations:
Other Medications:
Current Illness: Unknown
Preexisting Conditions:
Allergies:
Diagnostic Lab Data: UNK
CDC 'Split Type': B0607037A

Write-up: This case was reported by a foreign regulatory authority (Agency # GB-MHRA-ADR 20528079) and described the occurrence of epileptic fit in a 14-year-old female subject who was vaccinated with CERVARIX (GlaxoSmithKline). On 5 November 2009 the subject received an unspecified dose of CERVARIX (intramuscular, batch: AHPVA057CA). On 7 November 2009, 2 days after vaccination with the 2nd dose of CERVARIX, the subject experienced the first epileptic fit. The subject was hospitalised over night for observation. The subject had 2nd fits the next night and was due to be seen by consultant paediatrician in four months or sooner should a further fit occur. At the time of reporting the event was resolved. Agency Verbatim Text: Had 1st epileptic fit 2 days after receiving the 2nd dose of CERVARIX. Was admitted overnight for observation. Had 2nd fit the next night. Due to be seen by consultant paediatrician in four months or sooner should a further fit occur.

New Search

Link To This Search Result:

https://www.medalerts.org/vaersdb/findfield.php?IDNUMBER=370667&WAYBACKHISTORY=ON


Copyright © 2022 National Vaccine Information Center. All rights reserved.
21525 Ridgetop Circle, Suite 100, Sterling, VA 20166